ArticleBlood advances2022

Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels.

C Matthias Wilk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.